Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 226

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 226
---
 Taiwan.

Notice to Prospective Investors in Qatar

In the State of Qatar, the offer contained herein
is made on an exclusive basis to the specifically intended recipient thereof, upon that person’s request and initiative, for personal
use only and shall in no way be construed as a general offer for the sale of securities to the public or an attempt to do business as
a bank, an investment company or otherwise in the State of Qatar. This prospectus and the underlying securities have not been approved
or licensed by the Qatar Central Bank or the Qatar Financial Centre Regulatory Authority or any other regulator in the State of Qatar.
The information contained in this prospectus shall only be shared with any third parties in Qatar on a need to know basis for the purpose
of evaluating the contained offer. Any distribution of this prospectus by the recipient to third parties in Qatar beyond the terms hereof
is not permitted and shall be at the liability of such recipient.

Notice to Prospective Investors in Saudi Arabia

This prospectus may not be distributed in the
Kingdom of Saudi Arabia except to such persons as are permitted under the Offers of Securities Regulations issued by the Capital Market
Authority. The Capital Market Authority does not make any representation as to the accuracy or completeness of this prospectus, and expressly
disclaims any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this prospectus. Prospective
purchasers of the securities offered hereby should conduct their own due diligence on the accuracy of the information relating to the
securities. If you do not understand the contents of this prospectus you should consult an authorized financial adviser.

<div align='center'>129</div>

Notice to Prospective Investors in Singapore

This
prospectus has not been registered as a prospectus in Singapore with the Monetary Authority
of Singapore. Accordingly, this prospectus and any other documents or material in connection
with the offer or sale, or invitation for subscription or purchase, of the Class A Ordinary
Shares may not be circulated or distributed, nor may the Class A Ordinary Shares be offered
or sold, or be made the subject of an invitation for subscription or purchase, whether directly
or indirectly, to persons in Singapore other than (i) to an institutional investor under
Section 274 of the Securities and Futures Act, Chapter 289 of Singapore, or the
SFA, or (ii) to a relevant person pursuant to Section 275(1), or to any person
pursuant to Section 275(1A